UCB | Turning a Podcast Into a Thought Leadership Platform | Podcast Production

Challenge: Connecting Deeply in a Crowded Space

In highly specialised industries, podcasts offer an opportunity for organisations to connect deeply with key, highly engaged audiences, consistently and authentically.

When global biopharmaceutical company UCB approached us, they were aware of the value of their expertise to the industry. What they needed was a vehicle that would position them as a thought leader in pharmaceutical innovation, while maintaining the credibility and production quality expected from an international scientific audience.

A podcast series was the ideal platform to hold complex, nuanced ideas without flattening them, and bring UCB’s own experts into open conversation with the researchers, clinicians and innovators shaping their field from the outside (and inviting their audiences in with them).

In a regulated industry, the usual challenges of communication have an added dimension. Pharmaceutical companies don’t just face the pressure to get a message across, they operate under intense scrutiny, where every public-facing message carries reputational and compliance weight. Getting the tone wrong, oversimplifying a claim, or appearing to stray into promotional territory can have real consequences. 

Most organisations respond to that pressure by saying less, but UCB saw the opportunity presented by a podcast channel. It was a chance to own a space where they could demonstrate expertise rather than just assert it – steering the conversation and retaining editorial control, while still sparking interest through rigorous discussion, credible guests, and questions the industry was genuinely grappling with. 

 

Insight: Complex Ideas Need Room to Breathe

How do you speak to subject matter experts and highly informed audiences? You need to meet them where they are, and the depth provided by the podcast format is the perfect space to do so. 

For UCB, the strategic opportunity was clear: use the podcast medium not simply to distribute information, but to shape the conversation, positioning UCB’s leaders and partners as the people setting the agenda in pharmaceutical R&D. Here they can engage listeners by offering rigour, nuance, and a willingness to dive deep, building their reputation in the process. 

 

Solution: A Podcast Series Built for Substance and Scale

We delivered full end-to-end production for Hypothesise That! – a thought leadership podcast designed to place UCB at the centre of conversations in Pharma R&D. This included a companion series of bonus episodes under the Crimes Against Innovation banner.

Our team handled pre-production, including concept development, editorial planning, guest coordination and scheduling. Editorially, episodes were built around fascinating thought starters. 

From ‘Are wet labs becoming obsolete?’ to  ‘Should parts of the clinical trials industry be made redundant?’, episodes engage with the questions people in the industry are invested in. Framing UCB’s voice within honest, inquiry-led discussion rather than declarative brand messaging helped not only nurture the conversation, but also reassured informed audiences who are rightly sceptical of anything that feels like spin.

Episodes were filmed across multiple locations, including our studio and UCB’s offices in Brussels, using a comprehensive three-camera setup. This ensured a finished product that held its own on any platform, from Spotify, to LinkedIn to YouTube. Remote guest integration allowed international contributors, including Stanford University’s Professor Russ Altman and experts from the Decentralised Trials and Research Alliance, to participate seamlessly, expanding the calibre of the conversation without limiting it to geography.

In post-production, we delivered full audio and video edits, multi-camera mixing, sound design and music. As an integrated agency, we also made the most of the “many waves of broadcasting” and the modern content ecosystem by accompanying the episodes with social cutdowns and teaser clips that were engineered for shareability and designed to pull new audiences into the longer conversation. 

 

Impact: Podcast Reach, Reputation, and Relationships

The result was a polished, globally relevant series that elevated UCB’s voice within the pharmaceutical innovation space. The podcast enabled the brand to engage leading experts in meaningful discussions while extending its thought leadership reach across multiple platforms. Here’s what that meant in a little more depth.

Thought leadership. By hosting conversations with figures like UCB’s Chief Scientific Officer and leading academics, the series didn’t just reflect UCB’s expertise; it demonstrated it in real time, in dialogue with the people who matter most to their industry. In a sector where trust is hard-won and easily lost, that kind of peer-level conversation carries a different kind of weight than traditional brand communications.

Audiences became advocates. Listeners who engage with long-form content aren’t passive; they become invested. When UCB’s stakeholders – partners, researchers, potential collaborators – encountered Hypothesise That!, they were being brought into a conversation. This builds a fundamentally different relationship than that of a straight marketing message, and a far stickier one.

A platform, not just a project. What began as a podcast series became an ongoing content infrastructure – one that could grow with new series, new guests, and new topics. The Crimes Against Innovation bonus episodes extended the format into adjacent territory, demonstrating the scalability of the approach.

Multi-platform presence. With video, audio, and social content produced in parallel, UCB amplified a single conversation across every channel their audiences used, without diluting the quality or message at any touchpoint.

 

Conclusion

Every sector has complexity, and many navigate compliance pressures too. In this space, podcasts help you communicate more carefully and credibly, and truly engage with your audience’s intelligence. By making space for the real conversations that your experts are already having internally and your customers are having amongst themselves, you transform “brand comms” into something that not only wins audience trust, but becomes a real resource in its own right.